Journal Article Summary
The article investigates how different growth media affect the sensitivity of multidrug-resistant (MDR) Pseudomonas aeruginosa to azithromycin, particularly in cystic fibrosis (CF) patients. This topic is significant because CF patients often suffer from chronic infections caused by P. aeruginosa, which can lead to severe lung complications and increased mortality. Azithromycin is commonly used as a long-term treatment option for these infections, but its effectiveness can vary based on the testing conditions used to determine bacterial resistance.
In this study, researchers analyzed 29 MDR P. aeruginosa isolates from CF patients, testing their sensitivity to azithromycin using three different media: cation-adjusted Mueller Hinton Broth (CA-MHB), Roswell Park Memorial Institute medium supplemented with fetal calf serum (RPMI/FCS), and synthetic cystic fibrosis sputum medium (SCFM). They found that while some isolates showed low minimum inhibitory concentrations (MICs) in RPMI/FCS, all isolates had high MICs in SCFM and CA-MHB, suggesting that azithromycin may not be effective against these bacteria in the CF airway environment. Additionally, mutations in the 23S rRNA gene, which are associated with azithromycin resistance, were identified in a significant portion of the isolates.
The study has limitations, including its retrospective design and the fact that it does not fully replicate the complex conditions of the CF airway. Patients and caregivers should be aware that the results indicate uncertainty regarding the effectiveness of azithromycin against P. aeruginosa in CF patients, especially those with MDR strains. It is essential for readers to discuss these findings with healthcare professionals to understand the implications for treatment options and to explore alternative therapies if necessary.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sörensen Michael, Khakimov Bakhodur, Nurjadi Dennis, Boutin Sébastien, Yi Buqing, Dalpke Alexander H., Eigenbrod Tatjana. Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients. Antimicrobial Resistance and Infection Control 2020. DOI: 10.1186/s13756-020-00859-7. PMID: 33298147. PMCID: PMC7724801.
Featured Pill Pals Product
Azithromycin 250 mg Tablet Six (6) Pack --- TEVA Pharma --- Generic For Z Pack / Zithromax
Azithromycin 250 mg Tablet Six (6) Pack — TEVA Pharma — Generic For Z Pack / Zithromax is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
